These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4605352)

  • 41. The controlled evaluation of a new tranquillizing drug medazepam in the treatment of anxiety.
    Silverstone JT; Carne HJ; Cooper RM; Dell AJ; Salkind MR
    Br J Clin Pract; 1971 Apr; 25(4):172-4. PubMed ID: 4930380
    [No Abstract]   [Full Text] [Related]  

  • 42. Control of acute alcoholic withdrawal symptoms: a comparative study of haloperidol and chlordiazepoxide.
    Palestine ML; Alatorre E
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):289-99. PubMed ID: 822987
    [No Abstract]   [Full Text] [Related]  

  • 43. Prognostic indicators of 4-week clinical improvement with chlordiazepoxide and hydroxyzine in anxious neurotic outpatients.
    Rickels K; Csanalosi I; Downing RW; Hesbacher PT
    Int Pharmacopsychiatry; 1971; 6(4):249-53. PubMed ID: 4950567
    [No Abstract]   [Full Text] [Related]  

  • 44. Bromazepam, medazepam, chlordiazepoxide in treatment of neurotic anxiety.
    Kerry RJ; McDermott CM; Orme JE
    Br J Psychiatry; 1974 May; 124(0):485-6. PubMed ID: 4836379
    [No Abstract]   [Full Text] [Related]  

  • 45. [Experience with fluphenazine in the treatment of anxiety in endogenous depressions. (Orientational comparison with chlorpromazine in an intensive double-blind study].
    Ledererová E; Toman M; Grof P
    Cesk Psychiatr; 1966 Aug; 62(4):254-60. PubMed ID: 5341087
    [No Abstract]   [Full Text] [Related]  

  • 46. Length of treatment with anxiolytic sedatives and response to their sudden withdrawal.
    Covi L; Lipman RS; Pattison JH; Derogatis LR; Uhlenhuth EH
    Acta Psychiatr Scand; 1973; 49(1):51-64. PubMed ID: 4572168
    [No Abstract]   [Full Text] [Related]  

  • 47. Controlled double-blind trial of camazepam, a new benzodiazepine derivative, versus chlordiazepoxide.
    Carrara S; Mauri M; Guazzelli M; Maggini C; Castrogiovanni P
    Eur J Clin Pharmacol; 1978 Jul; 13(5):335-7. PubMed ID: 27372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Response to trifluoperazine-amobarbital in outpatients with anxiety. (A double-blind, placebo-controlled study).
    Guthrie MB; Free SM
    Dis Nerv Syst; 1969 Mar; 30(3):195-200. PubMed ID: 4886703
    [No Abstract]   [Full Text] [Related]  

  • 49. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
    Shopsin B; Pearson E; Gershon S; Collins P
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of chlordiazepoxide in respiratory failure due to chronic bronchitis.
    Model DG; Berry DJ
    Lancet; 1974 Oct; 2(7885):869-70. PubMed ID: 4137638
    [No Abstract]   [Full Text] [Related]  

  • 51. Differential drug effects in neurotic depression.
    Rickels K; Hesbacher P; Downing RW
    Dis Nerv Syst; 1970 Jul; 31(7):468-75. PubMed ID: 4918448
    [No Abstract]   [Full Text] [Related]  

  • 52. Proceedings: Isolation-induced timidity in mice as a measure of anxiolytic activity of drugs.
    Krsiak M
    Act Nerv Super (Praha); 1974; 16(4):241-2. PubMed ID: 4476166
    [No Abstract]   [Full Text] [Related]  

  • 53. Implementation of psychotherapy by librium in a pioneering rural-industrial psychiatric practice.
    Podobnikar IG
    Psychosomatics; 1971; 12(3):205-9. PubMed ID: 4950860
    [No Abstract]   [Full Text] [Related]  

  • 54. A controlled study comparing a three times daily dose of chlordiazepoxide with a single night-time dose of Trancopal in the control of anxiety, using a double-blind, double-dummy technique.
    Donald JF; Molla AL
    J Int Med Res; 1978; 6(2):105-10. PubMed ID: 344083
    [No Abstract]   [Full Text] [Related]  

  • 55. [Benzodiazepine withdrawal syndrome in low dose dependency].
    Thomas H; Mörchen G
    Psychiatr Prax; 1996 Sep; 23(5):249-50. PubMed ID: 8992523
    [No Abstract]   [Full Text] [Related]  

  • 56. Doxepin in the treatment of psychoneurotic patients.
    Beaubien J; Ban TA; Lehman HE; Jarrold L
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):192-4. PubMed ID: 4985939
    [No Abstract]   [Full Text] [Related]  

  • 57. Differential effects of chlordiazepoxide and fluphenazine in two anxious patient populations.
    Rickels K; Raab E; Gordon PE; Laquer KG; DeSilverio RV; Hesbacher P
    Psychopharmacologia; 1968; 12(3):181-92. PubMed ID: 4917284
    [No Abstract]   [Full Text] [Related]  

  • 58. Anxiety in schizophrenia. The responses to chlordiazepoxide in an intensive design study.
    Kellner R; Wilson RM; Muldawer MD; Pathak D
    Arch Gen Psychiatry; 1975 Oct; 32(10):1246-54. PubMed ID: 241306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A double-blind comparison between loxapine and chlordiazepoxide in the treatment of anxiety [proceedings].
    Versiani M; Bueno J; Mundim F
    Psychopharmacol Bull; 1977 Apr; 13(2):22-4. PubMed ID: 323906
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of the acute alcohol withdrawal state: a comparison of four drugs.
    Kaim SC; Klett CJ; Rothfeld B
    Agressologie; 1968; 9(2):305-8. PubMed ID: 4877492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.